首页> 外文期刊>Journal of Clinical Microbiology >Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC β-Lactamase in P. mirabilis
【24h】

Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC β-Lactamase in P. mirabilis

机译:临床分离的奇异变形杆菌中的KPC-2的检测,以及首次报道的由奇异变形杆菌中KPCβ-内酰胺酶引起的碳青霉烯酶耐药性的描述

获取原文
           

摘要

An isolate of Proteus mirabilis recovered from blood cultures of a diabetic patient was shown to be resistant to imipenem, meropenem, and ertapenem by disk diffusion susceptibility testing. Amplification of whole-cell and/or plasmid DNA recovered from the isolate with primers specific for the blaKPC carbapenemase gene produced an amplicon of the expected size which was confirmed to be blaKPC-2 by sequence analysis. Transformation of a susceptible Escherichia coli host with plasmid preparations from the isolate generated a transformant for which the MICs of all of the carbapenems tested were increased three- to fourfold. We believe this to be the first report of carbapenem resistance in P. mirabilis caused by the acquisition of blaKPC.
机译:从糖尿病患者血液培养物中回收的 Proteus mirabilis 分离物通过纸片扩散敏感性测试显示对亚胺培南,美洛培南和厄他培南具有抗药性。用特异于 bla KPC 碳青霉烯酶基因的引物扩增从分离物中回收的全细胞和/或质粒DNA,产生了预期大小的扩增子,该扩增子被证实为< em> bla KPC-2 进行序列分析。用来自分离株的质粒制备物转化易感的大肠杆菌宿主,产生了转化子,所有测试的碳青霉烯的MIC均提高了三到四倍。我们认为这是 P 中碳青霉烯耐药性的首次报道。收购 bla KPC 导致的 mirabilis

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号